Patients deserve more options

We are focused on making a meaningful difference for patients by developing and commercializing innovative therapies for a range of urologic conditions, beginning with overactive bladder.

Photograph of middle-aged Hispanic man and woman embracing and smiling at each other as they walk on the beach
Photograph of middle-aged Hispanic man and woman embracing and smiling at each other as they walk on the beach
Photograph of middle-aged Hispanic man and woman embracing and smiling at each other as they walk on the beach
Overactive bladder (OAB)

A challenge for millions of Americans

For people with OAB, the symptoms of urgency, frequency (specifically the need to urinate eight or more times a day), and accidental leakage episodes can be disruptive and disturbing.

While OAB is not a life-threatening condition, coping with its daily symptoms can certainly be limiting. People living with symptoms of OAB may not realize that it's more common than they might think.

Globe Icon
546 million

Estimated number of people aged ≥20 years affected by OAB worldwide1

US Map Icon
33 million

Estimated number of US adults who experience symptoms of OAB2

The management gap

OAB is a problem for so many—yet why do so few talk to their doctor about it? Many people believe it's "just part of getting older" and are not aware that there may be ways to manage their condition. In addition, they are often embarrassed to mention their symptoms to anyone—including their doctor.2,3

At Urovant, we are committed to reducing the stigma of OAB.

45.7%

Percentage of US adults with probable OAB who discussed their symptoms with a healthcare provider4 (~15 million*)

8.1% of US adults with probable OAB are receiving treatment

Percentage of US adults with probable OAB who are receiving treatment4 (~3 million*)

*Number is calculated from estimated 33 million US adults with OAB symptoms.

Raising expectations in OAB care

Our sense of purpose is driven by the knowledge that what we do has a positive impact. The aim of our product development efforts is to improve the quality of care for patients living with urologic conditions. Our current areas of study include OAB and OAB in men with benign prostatic hyperplasia (BPH):

  • •

    OAB is the sudden urge to urinate that is difficult to control with or without accidental urinary leakage, and usually with increased frequency of urination.

  • •

    BPH is characterized by changes in the prostate, affecting the bladder outlet, which can prevent normal urine flow. Approximately 50% of BPH patients also suffer from OAB.5

Stay informed about Urovant advances in urologic care.

Latest news

REFERENCES: 1. Irwin DE, Kopp ZS, Agatep B, Milsom I, Abrams P. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int. 2011;108(7):‍11‍32‍-11‍38‍. doi:10.1111/j.1464-410X.2010.09993.x 2. Leron E, Weintraub AY, Mastrolia SA, Schwarzman P. Overactive bladder syndrome: evaluation and management. Curr Urol. 2017;11:117-125. doi:10.1159/000447205 3. Abrams P, Kelleher CJ, Kerr LA, Rogers RG. Overactive bladder significantly affects quality of life. Am J Manag Care. 2000;6(11 Suppl):S580-S590. 4. Benner JS, Becker R, Fanning K, et al. Bother related to bladder control and health care seeking behavior in adults in the United States. J Urol. 2009;181(6):‍25‍91‍-‍2‍59‍8. doi:10.1016/j.juro.2009.02.018 5. Eapen RS, Radomski SB. Review of the epidemiology of overactive bladder. Res Rep Urol. 2016;8:71-76. doi:10.2147/RRU.S102441